Urologix Stock Return On Equity
| ULGXDelisted Stock | USD 0.0001 0.00 0.00% |
Urologix fundamentals help investors to digest information that contributes to Urologix's financial success or failures. It also enables traders to predict the movement of Urologix Pink Sheet. The fundamental analysis module provides a way to measure Urologix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Urologix pink sheet.
Urologix |
Urologix Company Return On Equity Analysis
Urologix's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Urologix has a Return On Equity of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The return on equity for all United States stocks is 100.0% lower than that of the firm.
Urologix Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Urologix's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Urologix could also be used in its relative valuation, which is a method of valuing Urologix by comparing valuation metrics of similar companies.Urologix is currently under evaluation in return on equity category among its peers.
Urologix Fundamentals
| Return On Asset | -0.0762 | ||||
| Profit Margin | (0.39) % | ||||
| Operating Margin | (0.07) % | ||||
| Current Valuation | 4.92 M | ||||
| Shares Outstanding | 21.82 M | ||||
| Number Of Shares Shorted | 41.23 K | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 14.01 M | ||||
| Gross Profit | 5.9 M | ||||
| EBITDA | (373 K) | ||||
| Net Income | (7.61 M) | ||||
| Cash And Equivalents | 492 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 4.59 M | ||||
| Debt To Equity | (1.81) % | ||||
| Current Ratio | 0.56 X | ||||
| Book Value Per Share | (0.38) X | ||||
| Cash Flow From Operations | (1.53 M) | ||||
| Short Ratio | 1.02 X | ||||
| Earnings Per Share | (0.22) X | ||||
| Target Price | 1.5 | ||||
| Number Of Employees | 61 | ||||
| Beta | -80.48 | ||||
| Market Capitalization | 82.91 K | ||||
| Total Asset | 5.67 M | ||||
| Retained Earnings | (126.63 M) | ||||
| Working Capital | (612 K) | ||||
| Current Asset | 3.68 M | ||||
| Current Liabilities | 4.29 M | ||||
| Z Score | -28.8 | ||||
| Net Asset | 5.67 M |
About Urologix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Urologix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Urologix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Urologix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Urologix Pink Sheet
If you are still planning to invest in Urologix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Urologix's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |